CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
+21.32%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.39B
AUM Growth
+$1.39B
(+12%)
Cap. Flow
-$19.5M
Cap. Flow
% of AUM
-1.4%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
65
New
8
Increased
5
Reduced
40
Closed
4
Top Buys
| 1 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$43.4M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$27.3M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$24.8M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$17.2M |
| 5 |
Zai Lab
ZLAB
|
$9.25M |
Top Sells
| 1 |
Vanda Pharmaceuticals
VNDA
|
$18.2M |
| 2 |
Quanterix
QTRX
|
$17M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$13.3M |
| 4 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
$11.8M |
| 5 |
MTVA
MetaVia Inc. Common Stock
MTVA
|
$10.6M |
Sector Composition
| 1 | Healthcare | 95.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AnaptysBio
ANAB
$569M
| $113M | 7.36% | 1,135,000 -98,422 | -8% | -$9.82M |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $85.3M | 5.54% | 1,810,000 -108,350 | -6% | -$5.1M |
|
3
Nektar Therapeutics
NKTR
$568M
| $83.5M | 5.43% | 1,370,000 -130,000 | -9% | -$7.92M |
|
|
TECX
4
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $77.4M | 5.03% | 1,492,784 -14,999 | -1% | -$778K |
|
5
Apellis Pharmaceuticals
APLS
$3.48B
| $74.2M | 4.82% | 4,172,498 -140,000 | -3% | -$2.49M |
|
|
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $54.3M | 3.53% | 3,556,669 -44,285 | -1% | -$676K |
|
|
RETA
7
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $54M | 3.51% | 660,000 +210,000 | +47% | +$17.2M |
|
|
TSRO
8
DELISTED
TESARO, Inc.
TSRO
| $48.8M | 3.17% | 1,250,000 +700,000 | +127% | +$27.3M |
|
9
InflaRx
IFRX
$108M
| $46M | 2.99% | 1,341,540 -145,725 | -10% | -$5M |
|
|
MYOK
10
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $45.6M | 2.97% | 700,000 -67,363 | -9% | -$4.39M |
|
|
PRNB
11
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $43.4M | 2.82% | +1,486,898 | New | +$43.4M |
|
|
AUTL
12
Autolus Therapeutics
AUTL
$399M
| $40.7M | 2.64% | 1,326,136 -199,451 | -13% | -$6.12M |
|
13
Rocket Pharmaceuticals
RCKT
$354M
| $36.9M | 2.4% | 1,500,659 -19,231 | -1% | -$473K |
|
|
QTNT
14
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $36.6M | 2.38% | 4,850,000 +559,148 | +13% | +$4.22M |
|
15
Theravance Biopharma
TBPH
$699M
| $35.9M | 2.34% | 1,100,000 -200,000 | -15% | -$6.53M |
|
|
GTHX
16
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $33.5M | 2.18% | 640,481 -79,504 | -11% | -$4.16M |
|
17
Kezar Life Sciences
KZR
$28.9M
| $33.2M | 2.16% | 1,552,911 -19,999 | -1% | -$428K |
|
18
Solid Biosciences
SLDB
$427M
| $31.6M | 2.06% | 670,513 -15,443 | -2% | -$729K |
|
|
BPMC
19
DELISTED
Blueprint Medicines
BPMC
| $29.7M | 1.93% | 380,000 -170,000 | -31% | -$13.3M |
|
|
SAGE
20
DELISTED
Sage Therapeutics
SAGE
| $26.8M | 1.74% | 190,000 -49,619 | -21% | -$7.01M |
|
21
Ascendis Pharma
ASND
$11.8B
| $24.8M | 1.61% | 350,000 -21,739 | -6% | -$1.54M |
|
|
ZGNX
22
DELISTED
Zogenix, Inc.
ZGNX
| $24.8M | 1.61% | +500,000 | New | +$24.8M |
|
23
Omeros
OMER
$283M
| $24.4M | 1.59% | 1,000,000 -314,118 | -24% | -$7.67M |
|
|
TCDA
24
DELISTED
Tricida, Inc. Common Stock
TCDA
| $22.4M | 1.46% | 734,588 -200,000 | -21% | -$6.11M |
|
25
Neurocrine Biosciences
NBIX
$13.8B
| $21.5M | 1.4% | 175,000 -16,112 | -8% | -$1.98M |
|